ADMP near term Catalysts are NDA filing any day for generic Epipen, phase 3 trial generic Advair with newly acquired 3M inhaler & phase 3 trial on APC-1000 inhaled oral steroid for the treatment of asthma and COPD. Beximco is their partner on that one so s/b a busy 2014. Bottom line at 65 million dollar market cap with deep pipeline & potentially entering multiple different Billion dollar markets = one dirt cheap stock that no one knows about ..... except about 15 new Institutions loading up lol.... GLTY & make $$$$$$$$$$$
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.